• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Microbiome Therapeutics Market

United States Microbiome Therapeutics Market by Manufacturers, States, Type and Application, Forecast to 2023


The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult). 

Scope of the Report:
This report focuses on the Microbiome Therapeutics in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers"
    Seres Therapeutics
    Assembly Biosciences
    Synthetic Biologics
    Interxon
    PureTech
    Synlogic
    Enterome BioScience
    4D Pharma
    Second Genome
    AOBiome
    C3 Jian
    Rebiotix
    MicroBiome Therapeutics LLC
    Metabiomics
    Ritter Pharmaceuticals
    Symberix
    OpenBiome
    Azitra
    Symbiotix Biotherapies
    Osel
    Metabogen

Market Segment by States, covering
    California
    Texas
    New York
    Florida
    Illinois

Market Segment by Type, covers

Market Segment by Applications, can be divided into
    C. difficile Infection (CDI)
    Inflammatory Bowel Disease (IBD)
    Orphan Drug
    Immuno-oncology
    Others

There are 17 Chapters to deeply display the United States Microbiome Therapeutics market.

Chapter 1, to describe Microbiome Therapeutics Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Microbiome Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Microbiome Therapeutics, for each state, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue,   market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Microbiome Therapeutics market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers, etc.

Chapter 16 and 17, to describe Microbiome Therapeutics Research Findings and Conclusion, Appendix, methodology and data source.	
Table of Contents

1 Market Overview
    1.1 Microbiome Therapeutics Introduction
    1.2 Market Analysis by Type
    1.3 Market Analysis by Applications
        1.3.1 C. difficile Infection (CDI)
        1.3.2 Inflammatory Bowel Disease (IBD)
        1.3.3 Orphan Drug
        1.3.4 Immuno-oncology
        1.3.5 Others
    1.4 Market Analysis by States
        1.4.1 California Status and Prospect (2013-2023)
        1.4.2 Texas Status and Prospect (2013-2023)
        1.4.3 New York Status and Prospect (2013-2023)
        1.4.4 Florida Status and Prospect (2013-2023)
        1.4.5 Illinois Status and Prospect (2013-2023)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Seres Therapeutics
        2.1.1 Business Overview
        2.1.2 Microbiome Therapeutics Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Assembly Biosciences
        2.2.1 Business Overview
        2.2.2 Microbiome Therapeutics Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 Synthetic Biologics
        2.3.1 Business Overview
        2.3.2 Microbiome Therapeutics Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Interxon
        2.4.1 Business Overview
        2.4.2 Microbiome Therapeutics Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 PureTech
        2.5.1 Business Overview
        2.5.2 Microbiome Therapeutics Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Synlogic
        2.6.1 Business Overview
        2.6.2 Microbiome Therapeutics Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Enterome BioScience
        2.7.1 Business Overview
        2.7.2 Microbiome Therapeutics Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 4D Pharma
        2.8.1 Business Overview
        2.8.2 Microbiome Therapeutics Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 Second Genome
        2.9.1 Business Overview
        2.9.2 Microbiome Therapeutics Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 AOBiome
        2.10.1 Business Overview
        2.10.2 Microbiome Therapeutics Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 C3 Jian
        2.11.1 Business Overview
        2.11.2 Microbiome Therapeutics Type and Applications
            2.11.2.1 Type 1
            2.11.2.2 Type 2
        2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 Rebiotix
        2.12.1 Business Overview
        2.12.2 Microbiome Therapeutics Type and Applications
            2.12.2.1 Type 1
            2.12.2.2 Type 2
        2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.13 MicroBiome Therapeutics LLC
        2.13.1 Business Overview
        2.13.2 Microbiome Therapeutics Type and Applications
            2.13.2.1 Type 1
            2.13.2.2 Type 2
        2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.14 Metabiomics
        2.14.1 Business Overview
        2.14.2 Microbiome Therapeutics Type and Applications
            2.14.2.1 Type 1
            2.14.2.2 Type 2
        2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.15 Ritter Pharmaceuticals
        2.15.1 Business Overview
        2.15.2 Microbiome Therapeutics Type and Applications
            2.15.2.1 Type 1
            2.15.2.2 Type 2
        2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.16 Symberix
        2.16.1 Business Overview
        2.16.2 Microbiome Therapeutics Type and Applications
            2.16.2.1 Type 1
            2.16.2.2 Type 2
        2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.17 OpenBiome
        2.17.1 Business Overview
        2.17.2 Microbiome Therapeutics Type and Applications
            2.17.2.1 Type 1
            2.17.2.2 Type 2
        2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.18 Azitra
        2.18.1 Business Overview
        2.18.2 Microbiome Therapeutics Type and Applications
            2.18.2.1 Type 1
            2.18.2.2 Type 2
        2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.19 Symbiotix Biotherapies
        2.19.1 Business Overview
        2.19.2 Microbiome Therapeutics Type and Applications
            2.19.2.1 Type 1
            2.19.2.2 Type 2
        2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.20 Osel
        2.20.1 Business Overview
        2.20.2 Microbiome Therapeutics Type and Applications
            2.20.2.1 Type 1
            2.20.2.2 Type 2
        2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.21 Metabogen
        2.21.1 Business Overview
        2.2.2 Microbiome Therapeutics Type and Applications
            2.21.2.1 Type 1
            2.21.2.2 Type 2
        2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 United States Microbiome Therapeutics Market Competition, by Manufacturer
    3.1 United States Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
        3.1.1 United States Microbiome Therapeutics Sales by Manufacturer (2016-2017)
        3.1.2 United States Microbiome Therapeutics Sales Market Share by Manufacturer (2016-2017)
    3.2 United States Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
        3.2.1 United States Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
        3.2.2 United States Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
    3.3 United States Microbiome Therapeutics Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
        3.4.2 Top 5 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
    3.5 Market Competition Trend
4 United States Microbiome Therapeutics Market Analysis by States
    4.1 United States Microbiome Therapeutics Sales Market Share by States (2013-2018)
    4.2 United States Microbiome Therapeutics Sales and Market Share by States (2013-2018)
        4.2.1 United States Microbiome Therapeutics Sales by States (2013-2018)
        4.2.2 United States Microbiome Therapeutics Sales Market Share by States (2013-2018)
    4.3 United States Microbiome Therapeutics Revenue (Value) and Market Share by States (2013-2018)
        4.3.1 United States Microbiome Therapeutics Revenue by States (2013-2018)
        4.3.2 United States Microbiome Therapeutics Revenue Market Share by States (2013-2018)
5 United States Market Segmentation Microbiome Therapeutics by Type
    5.1 United States Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
        5.1.1 United States Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
        5.1.2 United States Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
    5.2 Type 1 Sales Growth Rate and Price
6 United States Market Segmentation Microbiome Therapeutics by Application
    6.1 United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
    6.2 C. difficile Infection (CDI) Sales Growth (2012-2017)
    6.3 Inflammatory Bowel Disease (IBD) Sales Growth (2012-2017)
    6.4 Orphan Drug Sales Growth (2012-2017)
    6.5 Immuno-oncology Sales Growth (2012-2017)
    6.6 Others Sales Growth (2012-2017)
7 California Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
    7.1 California Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
    7.2 California Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
        7.2.1 California Microbiome Therapeutics Sales by Type (2013-2018)
        7.2.2 California Microbiome Therapeutics Sales Market Share by Type (2013-2018)
    7.3 California Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
        7.3.1 California Microbiome Therapeutics Sales by Application (2013-2018)
        7.3.2 California Microbiome Therapeutics Sales Market Share by Application (2013-2018)
8 New York Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
    8.1 New York Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
    8.2 New York Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
        8.2.1 New York Microbiome Therapeutics Sales by Type (2013-2018)
        8.2.2 New York Microbiome Therapeutics Sales Market Share by Type (2013-2018)
    8.3 New York Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
        8.3.1 New York Microbiome Therapeutics Sales by Application (2013-2018)
        8.3.2 New York Microbiome Therapeutics Sales Market Share by Application (2013-2018)
9 Texas Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
    9.1 Texas Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
    9.2 Texas Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
        9.2.1 Texas Microbiome Therapeutics Sales by Type (2013-2018)
        9.2.2 Texas Microbiome Therapeutics Sales Market Share by Type (2013-2018)
    9.3 Texas Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
        9.3.1 Texas Microbiome Therapeutics Sales by Application (2013-2018)
        9.3.2 Texas Microbiome Therapeutics Sales Market Share by Application (2013-2018)
10 Florida Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
    10.1 Florida Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
    10.2 Florida Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
        10.2.1 Florida Microbiome Therapeutics Sales by Type (2013-2018)
        10.2.2 Florida Microbiome Therapeutics Sales Market Share by Type (2013-2018)
    10.3 Florida Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
        10.3.1 Florida Microbiome Therapeutics Sales by Application (2013-2018)
        10.3.2 Florida Microbiome Therapeutics Sales Market Share by Application (2013-2018)
11 Illinois Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
    11.1 Illinois Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
    11.2 Illinois Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
        11.2.1 Illinois Microbiome Therapeutics Sales by Type (2013-2018)
        11.2.2 Illinois Microbiome Therapeutics Sales Market Share by Type (2013-2018)
    11.3 Illinois Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
        11.3.1 Illinois Microbiome Therapeutics Sales by Application (2013-2018)
        11.3.2 Illinois Microbiome Therapeutics Sales Market Share by Application (2013-2018)
12 Microbiome Therapeutics Market Forecast (2018-2023)
    12.1 United States Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
    12.2 Microbiome Therapeutics Market Forecast by States (2018-2023)
        12.2.1 United States Microbiome Therapeutics Sales Forecast by States (2018-2023)
        12.2.2 United States Microbiome Therapeutics Market Share Forecast by States (2018-2023)
    12.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
        12.3.1 United States Microbiome Therapeutics Sales Forecast by Type (2018-2023)
        12.3.2 United States Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
    12.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
        12.4.1 United States Microbiome Therapeutics Sales Forecast by Application (2018-2023)
        12.4.2 United States Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
13 Microbiome Therapeutics Manufacturing Cost Analysis
    13.1 Microbiome Therapeutics Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Price Trend of Key Raw Materials
        13.1.3 Key Suppliers of Raw Materials
        13.1.4 Market Concentration Rate of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
        13.2.1 Raw Materials
        13.2.2 Labor Cost
        13.2.3 Manufacturing Expenses
    13.3 Manufacturing Process Analysis of Microbiome Therapeutics
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
    14.1 Microbiome Therapeutics Industrial Chain Analysis
    14.2 Upstream Raw Materials Sourcing
    14.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
    14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
    15.1 Sales Channel
        15.1.1 Direct Marketing
        15.1.2 Indirect Marketing
        15.1.3 Marketing Channel Future Trend
    15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
    17.1 Methodology
    17.2 Data Source

	List of Tables and Figures
Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure United States Sales Market Share of Microbiome Therapeutics by Types in 2017
Table Types of Microbiome Therapeutics
Figure United States Microbiome Therapeutics Sales Market Share by Applications in 2017
Table Applications of Microbiome Therapeutics
Figure C. difficile Infection (CDI) Picture
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure California Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Texas Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure New York Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Florida Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Illinois Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Microbiome Therapeutics Type and Applications
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table Assembly Biosciences Microbiome Therapeutics Type and Applications
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics Microbiome Therapeutics Type and Applications
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Interxon Basic Information, Manufacturing Base and Competitors
Table Interxon Microbiome Therapeutics Type and Applications
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PureTech Basic Information, Manufacturing Base and Competitors
Table PureTech Microbiome Therapeutics Type and Applications
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synlogic Basic Information, Manufacturing Base and Competitors
Table Synlogic Microbiome Therapeutics Type and Applications
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table Enterome BioScience Microbiome Therapeutics Type and Applications
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table 4D Pharma Basic Information, Manufacturing Base and Competitors
Table 4D Pharma Microbiome Therapeutics Type and Applications
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Second Genome Basic Information, Manufacturing Base and Competitors
Table Second Genome Microbiome Therapeutics Type and Applications
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AOBiome Basic Information, Manufacturing Base and Competitors
Table AOBiome Microbiome Therapeutics Type and Applications
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C3 Jian Basic Information, Manufacturing Base and Competitors
Table C3 Jian Microbiome Therapeutics Type and Applications
Table C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Microbiome Therapeutics Type and Applications
Table Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Type and Applications
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabiomics Basic Information, Manufacturing Base and Competitors
Table Metabiomics Microbiome Therapeutics Type and Applications
Table Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ritter Pharmaceuticals Microbiome Therapeutics Type and Applications
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symberix Basic Information, Manufacturing Base and Competitors
Table Symberix Microbiome Therapeutics Type and Applications
Table Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OpenBiome Basic Information, Manufacturing Base and Competitors
Table OpenBiome Microbiome Therapeutics Type and Applications
Table OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Azitra Basic Information, Manufacturing Base and Competitors
Table Azitra Microbiome Therapeutics Type and Applications
Table Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symbiotix Biotherapies Basic Information, Manufacturing Base and Competitors
Table Symbiotix Biotherapies Microbiome Therapeutics Type and Applications
Table Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Osel Basic Information, Manufacturing Base and Competitors
Table Osel Microbiome Therapeutics Type and Applications
Table Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabogen Basic Information, Manufacturing Base and Competitors
Table Metabogen Microbiome Therapeutics Type and Applications
Table Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Table United States Microbiome Therapeutics Sales Market Share by Manufacturer (2016-2017)
Figure United States Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure United States Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table United States Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Table United States Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
Figure United States Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure United States Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table United States Microbiome Therapeutics Price by Manufacturers (2016-2017)
Figure Top 3 Microbiome Therapeutics Manufacturer Market Share in 2016
Figure Top 3 Microbiome Therapeutics Manufacturer Market Share in 2017
Figure Top 5 Microbiome Therapeutics Manufacturer Market Share in 2016
Figure Top 5 Microbiome Therapeutics Manufacturer Market Share in 2017
Figure United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table United States Microbiome Therapeutics Sales by States (2013-2018)
Table United States Microbiome Therapeutics Sales Market Share by States (2013-2018)
Figure United States Microbiome Therapeutics Sales Market Share by States in 2013
Figure United States Microbiome Therapeutics Sales Market Share by States in 2017
Table United States Microbiome Therapeutics Revenue by States (2013-2018)
Figure United States Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table United States Microbiome Therapeutics Revenue Market Share by States (2013-2018)
Figure United States Microbiome Therapeutics Revenue Market Share by States in 2013
Figure United States Microbiome Therapeutics Revenue Market Share by States in 2017
Table United States Microbiome Therapeutics Sales by Type (2013-2018)
Table United States Microbiome Therapeutics Sales Share by Type (2013-2018)
Table United States Microbiome Therapeutics Revenue by Type (2013-2018)
Table United States Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table United States Microbiome Therapeutics Sales by Application (2012-2017)
Table United States Microbiome Therapeutics Sales Share by Application (2012-2017)
Figure United States C. difficile Infection (CDI) Sales Growth (2012-2017)
Figure United States Inflammatory Bowel Disease (IBD) Sales Growth (2012-2017)
Figure United States Orphan Drug Sales Growth (2012-2017)
Figure United States Immuno-oncology Sales Growth (2012-2017)
Figure United States Others Sales Growth (2012-2017)
Figure California Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure California Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table California Microbiome Therapeutics Sales by Type (2013-2018)
Table California Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table California Microbiome Therapeutics Sales by Application (2013-2018)
Table California Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Figure New York Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure New York Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table New York Microbiome Therapeutics Sales by Type (2013-2018)
Table New York Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table New York Microbiome Therapeutics Sales by Application (2013-2018)
Table New York Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Figure Texas Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Texas Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Texas Microbiome Therapeutics Sales by Type (2013-2018)
Table Texas Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Texas Microbiome Therapeutics Sales by Application (2013-2018)
Table Texas Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Figure Florida Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Florida Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Florida Microbiome Therapeutics Sales by Type (2013-2018)
Table Florida Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Florida Microbiome Therapeutics Sales by Application (2013-2018)
Table Florida Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Figure Illinois Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Illinois Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Illinois Microbiome Therapeutics Sales by Type (2013-2018)
Table Illinois Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Illinois Microbiome Therapeutics Sales by Application (2013-2018)
Table Illinois Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table United States Microbiome Therapeutics Sales Forecast by States (2018-2023)
Table United States Microbiome Therapeutics Market Share Forecast by States (2018-2023)
Table United States Microbiome Therapeutics Sales Forecast by Type (2018-2023)
Table United States Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
Table United States Microbiome Therapeutics Sales Forecast by Application (2018-2023)
Table United States Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microbiome Therapeutics
Figure Manufacturing Process Analysis of Microbiome Therapeutics
Figure Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
Table Major Buyers of Microbiome Therapeutics
Table Distributors/Traders/ Dealers List

Related Reports

Global Vapor Cartridge Industry Market Research Report

The Vapor Cartridge market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Vapor ...read more

Global Foot-And-Mouth Disease Vaccine Industry Market Research Report

The Foot-And-Mouth Disease Vaccine market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Bas ...read more

Global Galactosyl Transferases Industry Market Research Report

The Galactosyl Transferases market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on th ...read more

Global Hemorrhoids Drug Industry Market Research Report

The Hemorrhoids Drug market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Hemor ...read more

Global Meningococcal Polysaccharide Vaccine(Group A/C/Y/W135) Industry Market Research Report

The Meningococcal Polysaccharide Vaccine(Group A/C/Y/W135) market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.